educratsweb logo


CSIR’s Anti-Cancer Drug IIIM-290 enters Clinical Trial

CSIR constituent lab CSIR-Indian Institute of Integrative Medicine (IIIM) Jammu, has received Investigational New Drug (IND) approval from New Drugs Division of Central Drugs Standard Control Organization (CDSCO) for a potent anti-cancer, New Chemical Entity (NCE) effective against pancreatic cancer after successful completion of preclinical development and IND submission. This will pave way for CSIR- IIIM for conducting the clinical trial of this important drug candidate IIIM-290 in pancreatic cancer patients. The proposed clinical trial is aimed to assess the safety, tolerability and exposure of the compound in humans along with the early efficacy indicators in pancreatic cancer patients. This drug was discovered and developed at the natural-products driven drug discovery program of CSIR-IIIM.

Dr. Shekhar Mande, DG, CSIR complemented team of scientists Sandip Bharate, Sonali Bharate, Dilip Mondhe, Shashi Bhushan and Sumit Gandhi who were led by Dr. Ram Vishwakarma, Director of CSIR-IIIM, on this significant milestone. They conducted close to a decade of high-end research as a prelude to granting of regulatory approval for clinical trials against pancreatic cancer.

Dr Ram Vishwakarma, highlighting the R&D carried out, informed that the anti-cancer screening against NCI-60 cancer cell lines panel and clinically validated protein kinase enzymes involved in cancer provided in 2011, provided an initial potent hit (rohitukine, a pure molecule natural product from the leaves of a tree from the Western Ghats Dysoxylum binectariferum,commonly known as Indian white cedar). Further medicinal chemistry designed to address efficacy/selectivity against a class of cell-cycle regulatory kinases (i.e. cyclin-dependent kinases) identified this preclinical candidate IIIM-290 showing excellent pharmacokinetics, oral bioavailability and potent anticancer activity in a number of animal xenograft models, with the best activity against the pancreatic cancer model. In the last three years, researchers completed all the pre-clinical safety, regulatory and other IND enabling studies, obtained global patents and published in, the Journal of Medicinal Chemistry in 2018.

Pertinently, the Pancreatic cancer currently ranks 12th among most common cancers in the world but has the notorious distinction of being the 4th leading cause of cancer-related deaths. The incidence of pancreatic cancer in India is 0.5–2.4 per 100,000 men and 0.2–1.8 per 100,000 women. Globally, it causes more than a quarter of a million deaths annually. This cancer is considered as one of the untreatable cancer type, because of its very late diagnosis and therefore there is a huge scarcity of drugs for the treatment of this cancer. This indigenous drug discovery program based on natural products opens potential therapeutic options for pancreatic cancer.

https://www.pib.gov.in/PressReleasePage.aspx?PRID=1630317

CSIR Anti-Cancer Drug IIIM-290 enters Clinical Trial
Contents shared By educratsweb.com

ICMR और Bharat Biotech के Covaxin के Human Trial पर गम्भीर सवाल | Covid-19 | Vaccine | 15 August #News - Published on Thursday July 9 2020
if you have any information regarding Job, Study Material or any other information related to career. you can Post your article on our website. Click here to Register & Share your contents.
For Advertisment or any query email us at educratsweb@gmail.com

RELATED POST
1 Simba Movie trailer Download | Talented India 
2 आरबीआई दे रहा नौकरी का सुनहरा मौका
3
4 शिवराज का मप्र की राजनीति से अध्याय खत्म
5 PhonePe Scratch Card Offers - Chance to Earn Rs. 1000 Per Money Transfer
6 IPL auction: Learn base price of players
7 CG Vyapam Recruitment 2019 : कई पदों पर भर्तियां
8 Best Skin Doctor in Delhi
9 Union Power Ministry writes to States/UTs extending Rs 90,000 crore package under Atmanirbhar Bharat Abhiyan
10 COVID-19: Relaxation from lockdown in Green zones
11 Transformation of manufacturing companies post COVID-19,Research be brought closer to Industryand collaborations in overcoming COVID 19 challenge:
12 Transformation of manufacturing companies post COVID-19,Research be brought closer to Industryand collaborations in overcoming COVID 19 challenge:
13 CSIR-IIIM & Reliance Industries Limited (RIL) to develop RT-LAMP based test for Coronavirus
14 NDMA(MHA) issues guideline on restarting manufacturing industries after the lockdown period
15 Bhagalpur Smart City uses innovative technological initiatives to fight COVID19
16 Various organizations and companies are showcasing their products in the exposition through a digital B2B lounge
17 Pradhan Mantri Matsya Sampada Yojana (PMMSY) aims to enhance fish production to 220 LMT with an investment of over Rs.20,000 crores in next five years
18 Proud moment for Indian Railways, as it became 6th country in the world to join the elite club of producing high horse power locomotive indegenously.
19 Health Ministry has issued guidelines for international arrivals.
20 IIT Guwahati discovers new ways to prevent memory loss due to Alzheimer
21 Health Secretary interacts with 11 COVID-19 high case load municipal areas
22 Union Minister Dr. Jitendra Singh launches Booklet and its e-version on one year achievements of Ministry of DoNER under Modi Government 2.0
23 MSME Minister Gadkari bats for technology upgradation and attracting foreign investment to combat post COVID scenario
24 Rs.1500 Crore disbursed at the door step using Aadhar enabled Payment System (AePS)
25 CSIR Anti-Cancer Drug IIIM-290 enters Clinical Trial
26 Five tips on how to live with novel coronavirus
27 200 special trains to run across the country starting 1st June 2020
28 Around 76 Online Job Fairs conducted by NCS during lockdown
29 Twitter handle @LabourDG inaugurated by Shri Santosh Gangwar
30 On World Turtle Day, Jal Shakti Minister gives clarion call to save aquatic animals
31 Urban Forest scheme to develop 200 Nagar Van across the country in next five years
32 Cabinet approves renaming of Kolkata Port Trust as Syama Prasad Mookerjee Trust
33 Shri Dharmendra Pradhan dedicates 56 CNG stations spread over 11 States/UTs;
34 Innovative disinfection & sanitization solutions by common people selected in NIF’s Challenge COVID-19 Competition (C3)
35 Free online career skills training launched on National Career Service portal in partnership with TCS ion
36 Ultraviolet Disinfection Facilities Developed AT Western Naval Command
37 6 states and over 180 investors participate in webinar chaired by Union FPI Minister
38 Over 16,000 applications received for CSIR’s Summer Research Training Programme
39 DRDO develops Ultra Swachh for disinfection of PPEs and other materials
40 Consumer Price Index for Industrial Workers (CPI-IW) – April, 2020
41 Sports Ministry to establish 1000 district-level Khelo India centers to engage past champions in sports training
42 Shri Pralhad Joshi launches R&D Portal for AatmaNirbhar Bharat in Mining Advancement
43 Cabinet approves renaming of Kolkata Port Trust as Syama Prasad Mookerjee Trust
44 MSDE-IBM Partnership Unveils Free Digital Learning Platform “Skills Build Reignite” to Reach More Job Seekers & Provide New Resources to Business Owners in India
45 Over 3000 COVID-19 samples tested at CSIR-NEERI
46 COVID-19 serves as a clarion call to achieve Atmanirbhar Bharat, says Dr Raghunath Mashelkar
47 Center Bolsters Efforts for COVID Management in Delhi
48 Prime Minister Garib Kalyan Package-Progress So Far
49 Ministry of Home Affairs (MHA) issues new Guidelines for Unlock 2
50 Under Make in India initiative in locust control, trials of prototype vehicle mounted ULV sprayer have been successfully conducted in Ajmer and Bikaner; approvals required for commercial launch are underway
We would love to hear your thoughts, concerns or problems with anything so we can improve our website educratsweb.com ! visit https://forms.gle/jDz4fFqXuvSfQmUC9 and submit your valuable feedback.
Save this page as PDF | Recommend to your Friends

http://educratsweb(dot)com http://educratsweb.com/content.php?id=2575 http://educratsweb.com educratsweb.com educratsweb